Taysha Gene Therapies (TSHA) Reports In-Line Q3 EPS

Go back to Taysha Gene Therapies (TSHA) Reports In-Line Q3 EPS
(NASDAQ: TSHA) Delayed: 5.71 +0.13 (2.33%)
Previous Close $5.58    52 Week High
Open $5.58    52 Week Low
Day High $6.06    P/E N/A 
Day Low $5.55    EPS
Volume 2,027,232